✦ LIBER ✦

PDB20 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY

✍ Scribed by T Doležal; Z Písaríková; K Rychna; M Honka; D Bartášková

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB30 A MODELLED COST-EFFECTIVENESS ANAL

✍ L Stechemesser; R Weitgasser; M Hofmann; M Aagren; R Mihaljev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PDB33 EVALUATING THE COST-EFFECTIVENESS

✍ L. Yang; A.L. Lay; J.H. Chang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Cost-Effectiveness of Switching Patients

✍ Li Yang; Torsten Christensen; Fengyu Sun; Jinghua Chang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

PDB24 LONG-TERM CLINICAL AND COST OUTCOM

✍ JP Clegg; WJ Valentine; K Rychna; M Honka; T Dolezal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

CE1 COST-EFFECTIVENESS OF SWITCHING PATI

✍ L Yang; T Christensen; J White; F Sun 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB